Pfizer Breast Cancer Drug Superior to Chemotherapy in Late Stage Study - U.S. News & World Report

U.S. News & World Report
Pfizer Breast Cancer Drug Superior to Chemotherapy in Late Stage Study
U.S. News & World Report
A logo of Pfizer is displayed on a monitor outside of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson Reuters. By Bill Berkrot. (Reuters) - Patients with advanced breast cancer tied ...
Pfizer's Medivation breast cancer PARP boosts PFS in phase 3FierceBiotech
Pfizer breast cancer drug superior to ch